144 related articles for article (PubMed ID: 34994965)
1. Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument.
Jandhyala R
Pharmaceut Med; 2022 Feb; 36(1):47-57. PubMed ID: 34994965
[TBL] [Abstract][Full Text] [Related]
2. Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method.
Jandhyala R; Rout R
Curr Med Res Opin; 2023 Dec; 39(12):1541-1550. PubMed ID: 36632732
[TBL] [Abstract][Full Text] [Related]
3. Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry.
Jandhyala R
F1000Res; 2022; 11():813. PubMed ID: 36415210
[No Abstract] [Full Text] [Related]
4. Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians.
Jandhyala R
Front Pharmacol; 2022; 13():842431. PubMed ID: 35273511
[No Abstract] [Full Text] [Related]
5. Development, validation and implementation of the medical affairs pharmaceutical physician work-related quality of life instrument.
Jandhyala R
Curr Med Res Opin; 2023 Dec; 39(12):1567-1574. PubMed ID: 36719367
[TBL] [Abstract][Full Text] [Related]
6. The multiple stakeholder approach to real-world evidence (RWE) generation: observing multidisciplinary expert consensus on quality indicators of rare disease patient registries (RDRs).
Jandhyala R
Curr Med Res Opin; 2021 Jul; 37(7):1249-1257. PubMed ID: 33989087
[TBL] [Abstract][Full Text] [Related]
7. Development of a definition for real-world evidence using the Jandhyala method for observing consensus opinion among medical affairs pharmaceutical physicians.
Jandhyala R
Curr Med Res Opin; 2023 Dec; 39(12):1551-1558. PubMed ID: 36710630
[TBL] [Abstract][Full Text] [Related]
8. A medicine adoption model for assessing the expected effects of additional real-world evidence (RWE) at product launch.
Jandhyala R
Curr Med Res Opin; 2021 Sep; 37(9):1645-1655. PubMed ID: 34176383
[TBL] [Abstract][Full Text] [Related]
9. Pedi-R-MAPP: The development of a nutritional awareness tool for use in remote paediatric consultations using a modified Delphi consensus.
Marino LV; Collaço NC; Ashton JJ; Cader S; Cooke ML; Cooke LH; Gerasimidis K; Guz-Mark A; Hulst JM; Vranesic Bender D; Huysentruyt K; Joosten K; Kolacek S; Krznaric Z; Meyer R; Nemet D; Niseteo T; Selimoglu MA; Shamir R; Darlington ASE; Beattie RM
Clin Nutr; 2022 Mar; 41(3):661-672. PubMed ID: 35149245
[TBL] [Abstract][Full Text] [Related]
10. Identifying Outcome Measures for Migraine Value-Based Contracting Using the Delphi Method.
Swart ECS; Good CB; Henderson R; Manolis C; Yanta C; Parekh N; Neilson LM
Headache; 2020 Nov; 60(10):2139-2151. PubMed ID: 32997806
[TBL] [Abstract][Full Text] [Related]
11. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
12. Determination of Multiple Sclerosis Indicators for Value-Based Contracting Using the Delphi Method.
Swart ECS; Neilson LM; Good CB; Shrank WH; Henderson R; Manolis C; Parekh N
J Manag Care Spec Pharm; 2019 Jul; 25(7):753-760. PubMed ID: 31232201
[TBL] [Abstract][Full Text] [Related]
13. 360-degree Delphi: addressing sociotechnical challenges of healthcare IT.
Waldmüller H; Spreckelsen C; Rudat H; Krumm N; Rolke R; Jonas SM
BMC Med Inform Decis Mak; 2020 Jun; 20(1):101. PubMed ID: 32503609
[TBL] [Abstract][Full Text] [Related]
14. Building a sustainable rural physician workforce.
Ostini R; McGrail MR; Kondalsamy-Chennakesavan S; Hill P; O'Sullivan B; Selvey LA; Eley DS; Adegbija O; Boyle FM; Dettrick Z; Jennaway M; Strasser S
Med J Aust; 2021 Jul; 215 Suppl 1():S5-S33. PubMed ID: 34218436
[TBL] [Abstract][Full Text] [Related]
15. Studies on macromolecular activators of phagocytosis from platelets (MAPPs) using anti MAPP murine monoclonal antibodies.
Yokoya Y; Sakamoto H; Oryu M; Uda H
Br J Haematol; 1992 Jun; 81(2):241-6. PubMed ID: 1643021
[TBL] [Abstract][Full Text] [Related]
16. Evolving role of pharmaceutical physicians in medical evidence and education.
Setia S; Ryan NJ; Nair PS; Ching E; Subramaniam K
Adv Med Educ Pract; 2018; 9():777-790. PubMed ID: 30464675
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.
Jandhyala R
Pharmaceut Med; 2020 Apr; 34(2):127-134. PubMed ID: 32048216
[TBL] [Abstract][Full Text] [Related]
19. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
20. Medicine adaptive pathways to patients (MAPPs): using regulatory innovation to defeat Eroom's law.
Schulthess D; Chlebus M; Bergstrӧm R; Baelen KV
Chin Clin Oncol; 2014 Jun; 3(2):21. PubMed ID: 25841417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
